Nath Bio-Genes (India) Limited — Board Meeting, 23-10-2024: Outcome of Board Meeting

Nath Bio-Genes (India) Limited's Board has approved the unaudited financial results for the quarter and half-year ended September 30, 2024. The company reported a net profit of ₹288.91 lakhs for the quarter. Additionally, Devinder Khurana relinquished his role as CFO, effective October 23, 2024, with Amol Gupta appointed as the new CFO. The results and details of management changes are available on the company's website.